Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Doxepin 25mg capsules
0403010L0AAABAB
|
Doxepin | Doxepin | Central Nervous System | 3,436 |
|
Doxepin 50mg capsules
0403010L0AAACAC
|
Doxepin | Doxepin | Central Nervous System | 2,180 |
|
Doxepin 10mg capsules
0403010L0AAAAAA
|
Doxepin | Doxepin | Central Nervous System | 118 |
|
Doxepin 50mg/5ml oral liquid
0403010L0AAAEAE
|
Doxepin | Doxepin | Central Nervous System | 7 |
|
Doxepin 75mg capsules
0403010L0AAADAD
|
Doxepin | Doxepin | Central Nervous System | No data available |
|
Sinepin 25mg capsules
0403010L0BCAAAB
|
Sinepin | Doxepin | Central Nervous System | No data available |
|
Sinepin 50mg capsules
0403010L0BCABAC
|
Sinepin | Doxepin | Central Nervous System | No data available |
|
Sinequan 10mg capsules
0403010L0BBAAAA
|
Sinequan | Doxepin | Central Nervous System | No data available |
|
Sinequan 25mg capsules
0403010L0BBABAB
|
Sinequan | Doxepin | Central Nervous System | No data available |
|
Sinequan 50mg capsules
0403010L0BBACAC
|
Sinequan | Doxepin | Central Nervous System | No data available |
|
Sinequan 75mg capsules
0403010L0BBADAD
|
Sinequan | Doxepin | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.